beam
Beam is a drug used to treat Hodgkin Disease, Hodgkin Lymphoma, Lymphoma, and other conditions. Beam is being actively studied in 1 study and prior, has been studied in 2.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Fondazione Italiana Linfomi ONLUS | A O Papardo | Julie M Vose, MD |
National Cancer Institute (NCI) | A.O. Niguarda | Kevin Conlon, MD |
University Hospital Inselspital, Berne | A.O. SS. Antonio e Biagio e C. Arrigo |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Completed
- Lymphoma, Large B-Cell, Diffuse
- +2 more
- BeEAM
- BEAM
- Linz, Austria
- +3 more
2021-07-29
Jul 29, 2021N
Terminated
- Hodgkin Disease
- Hodgkin Lymphoma
- Auto stem cell transplant
- +3 more
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2021-09-16
Sep 16, 2021F
Active, not recruiting
- Relapsed Follicular Lymphoma
- ZEVALIN
- BEAM
- Genova, GE, Italy
- +37 more
2021-11-11
Nov 11, 2021U
Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma - 2009
Completed
- Lymphoma
- Rituxan
- +2 more
- Omaha, NebraskaUniversity of Nebraska Medical Center, Section of Oncology/Hemat
2018-01-13
Jan 13, 2018